Literature DB >> 9987849

Analysis of changes during subclone development and ageing of human antibody-producing heterohybridoma cells by northern blot and flow cytometry.

N Borth1, K Strutzenberger, R Kunert, W Steinfellner, H Katinger.   

Abstract

The economic importance of obtaining high-producing subclones for large scale production of pharmaceutical proteins is self-evident. However, few papers have studied the changes that occur during subclone development. This information would be important for further improvement of screening and subcloning protocols. We have therefore compared subclones of a human-mouse heterohybridoma cell line producing a human antibody againt HIV-1. Three subclones with low, medium and high specific production rates were selected for this study and their light and heavy chain mRNA content, the intracellular content of light and heavy chain and the specific secretion rates compared. In addition the long time stability of antibody expression in the highest producing subclone was analysed for one year. For the three subclones a correlation between the intracellular content in light chain and the secretion rate was found, while the intracellular content in heavy chain was the same for all three subclones. These results indicate that the assembly in the endoplasmic reticulum (ER) is one of the major rate limiting factors in antibody production. During long time cultivation of the heterohybridoma cell line a continuous decrease in light and heavy chain production was seen without the appearance of a non producing sub-population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9987849     DOI: 10.1016/s0168-1656(98)00162-x

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  4 in total

1.  Anti-TNFα domain antibody construct CEP-37247: Full antibody functionality at half the size.

Authors:  Robert D Gay; Adam W Clarke; Zehra Elgundi; Teresa Domagala; Raina J Simpson; Nga B Le; Anthony G Doyle; Phil A Jennings
Journal:  MAbs       Date:  2010-11-01       Impact factor: 5.857

2.  Screening and selection strategy for the establishment of biosimilar to trastuzumab-expressing CHO-K1 cell lines.

Authors:  Thailin Lao-Gonzalez; Alexi Bueno-Soler; Arnelys Duran-Hernandez; Katya Sosa-Aguiar; Luis Eduardo Hinojosa-Puerta; Tays Hernandez-Garcia; Kathya Rashida de la Luz-Hernandez; Julio Palacios-Oliva; Tammy Boggiano-Ayo
Journal:  AMB Express       Date:  2021-01-03       Impact factor: 3.298

3.  Using molecular markers to characterize productivity in Chinese hamster ovary cell lines.

Authors:  Raihana Z Edros; Susan McDonnell; Mohamed Al-Rubeai
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

4.  Enhancing antibody folding and secretion by tailoring the Saccharomyces cerevisiae endoplasmic reticulum.

Authors:  Jorg C de Ruijter; Essi V Koskela; Alexander D Frey
Journal:  Microb Cell Fact       Date:  2016-05-23       Impact factor: 5.328

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.